Incidental prostate cancer (IPCa) is encountered in 10% of surgical procedures for benign prostatic obstruction (BPO). Identification of patients with underlying detrimental prostate cancer is paramount for tailored treatment decision-making, but guideline recommendations for this setting are lacking.
Predictors of Unfavorable Pathology in Patients with Incidental (pT1a-T1b) Prostate Cancer
Zattoni, Fabio;Dal Moro, Fabrizio;Morlacco, Alessandro;Collavino, Jeanlou;
2022
Abstract
Incidental prostate cancer (IPCa) is encountered in 10% of surgical procedures for benign prostatic obstruction (BPO). Identification of patients with underlying detrimental prostate cancer is paramount for tailored treatment decision-making, but guideline recommendations for this setting are lacking.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Mor-1-s2.0-S2405456922000633-main.pdf
Accesso riservato
Tipologia:
Published (Publisher's Version of Record)
Licenza:
Accesso privato - non pubblico
Dimensione
394.84 kB
Formato
Adobe PDF
|
394.84 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
